Karriereverlauf von Allen Hodge
Ehemalige bekannte Positionen von Allen Hodge
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 15.01.2020 | 01.07.2022 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Vertrieb & Marketing | 01.01.2012 | 01.01.2015 |
Ausbildung von Allen Hodge
Arkansas Tech University | Undergraduate Degree |
Boston University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Israel | 2 |
Operativ
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
- Börse
- Insiders
- Allen Hodge
- Erfahrung